Company Overview of Cobalis Corp.
Cobalis Corp., a development stage company, engages in the development and commercialization of pharmaceutical products for allergic diseases. Its product includes PreHistin, a phase III clinical trial product candidate for the treatment of atopic allergic diseases, including seasonal and year-round allergies, migraine, dermatitis, food allergies, and asthma. The company was incorporated in 2000 and is based in Irvine, California. On November 19, 2007, the involuntary petition of Cobalis Corp. for liquidation under Chapter 7 bankruptcy was converted to voluntary Chapter 11 reorganization. The involuntary petition was filed on August 1, 2007.
2030 Main Street
Irvine, CA 92614
Founded in 2000
Key Executives for Cobalis Corp.
Cobalis Corp. does not have any Key Executives recorded.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Cobalis Corp., please visit www.cobalis.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.